Marimed (MRMD) Profit After Tax (QoQ) (2011 - 2026)
Marimed (MRMD) Profit After Tax (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.01 Bn | 20.86 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.02 Bn | 22.02 Bn | - |
| 7 | Viatris | 20.40 Bn | 18.59 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.74 Bn | 12.31 Bn | 785.00 Mn |
| 10 | Marimed | 25.72 Mn | 17.78 Mn | 15.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.44% |
| Dec 31, 2025 | -57.43% |
| Sep 30, 2025 | -111.33% |
| Jun 30, 2025 | 74.54% |
| Mar 31, 2025 | 34.00% |
| Dec 31, 2024 | -725.15% |
| Sep 30, 2024 | 43.45% |
| Jun 30, 2024 | -27.34% |
| Mar 31, 2024 | 86.26% |
| Dec 31, 2023 | -138.76% |
| Sep 30, 2023 | -355.51% |
| Jun 30, 2023 | -40.81% |
| Mar 31, 2023 | -114.41% |
| Dec 31, 2022 | 70.33% |
| Sep 30, 2022 | 42.72% |
| Jun 30, 2022 | -55.29% |
| Mar 31, 2022 | 169.42% |
| Dec 31, 2021 | -387.75% |
| Sep 30, 2021 | -72.03% |
| Jun 30, 2021 | 79.83% |